Drug-coated stent for narrowed vertebral arteries
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial studies whether a drug-coated stent placed in a narrowed vertebral artery can improve outcomes for people with artery narrowing from plaque. It also looks at how safe the stent is, since it requires specific blood-thinning medicines around the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old (any gender)
- Have a narrowed vertebral artery from plaque (atherosclerotic vertebral artery stenosis)
- Be able and willing to understand the study and sign informed consent
- Be able to take two blood-thinning medicines (dual antiplatelet therapy) unless your doctor says it’s unsafe
- No major bleeding risk—such as active stomach/intestinal bleeding
- Not have certain recent major strokes/heart attacks, uncontrolled blood pressure, or serious short life expectancy (<12 months)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests using a drug-coated stent (a small tube that helps keep the artery open and slowly releases medicine) along with a shorter course of blood-thinning medicines to prevent another stroke in people who have a narrowed vertebral artery in the neck that has already caused symptoms.
This study compares a drug-coated stent placed in a neck (vertebral) artery versus best medical treatment with medicines and risk-factor control. It aims to reduce problems caused by a badly narrowed artery after recent stroke-like symptoms.
This study tests a special stent that slowly releases a drug (rapamycin) to keep a narrowed brain artery open. It is for patients who have had strokes despite medical treatment.
This trial tests a new type of stent coated with a medicine to treat narrowed brain arteries. It may help reduce the risk of future strokes compared to standard treatment.
This trial tests a special balloon catheter coated with a drug (sirolimus) to treat narrowed arteries inside the brain caused by atherosclerosis (plaque buildup). The goal is to keep the artery open and prevent future strokes.
This trial tests whether placing a stent in a severely narrowed brain artery, along with aggressive medication, can prevent another stroke better than medication alone. It is for people who had a mild stroke within the last 30 days due to a 70-99% blockage in a major brain artery.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.